Nano-palladium is a cellular catalyst for in vivo chemistry

Palladium (Pd) is a well-known catalyst in organic chemistry but its use in nanomedicine is limited. Here, the authors design a Pd nanoparticle that triggers the activation of an antitumour prodrugin vivo, which shows efficacy and improves toxicity compared to traditional solvent- and nanoparticle-d...

Full description

Bibliographic Details
Main Authors: Miles A. Miller, Bjorn Askevold, Hannes Mikula, Rainer H. Kohler, David Pirovich, Ralph Weissleder
Format: Article
Language:English
Published: Nature Portfolio 2017-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms15906
_version_ 1818990656082673664
author Miles A. Miller
Bjorn Askevold
Hannes Mikula
Rainer H. Kohler
David Pirovich
Ralph Weissleder
author_facet Miles A. Miller
Bjorn Askevold
Hannes Mikula
Rainer H. Kohler
David Pirovich
Ralph Weissleder
author_sort Miles A. Miller
collection DOAJ
description Palladium (Pd) is a well-known catalyst in organic chemistry but its use in nanomedicine is limited. Here, the authors design a Pd nanoparticle that triggers the activation of an antitumour prodrugin vivo, which shows efficacy and improves toxicity compared to traditional solvent- and nanoparticle-drug formulations.
first_indexed 2024-12-20T19:57:50Z
format Article
id doaj.art-b929185b46444f18bedc3e0efd655654
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-20T19:57:50Z
publishDate 2017-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-b929185b46444f18bedc3e0efd6556542022-12-21T19:28:08ZengNature PortfolioNature Communications2041-17232017-07-018111310.1038/ncomms15906Nano-palladium is a cellular catalyst for in vivo chemistryMiles A. Miller0Bjorn Askevold1Hannes Mikula2Rainer H. Kohler3David Pirovich4Ralph Weissleder5Center for Systems Biology, Massachusetts General HospitalCenter for Systems Biology, Massachusetts General HospitalCenter for Systems Biology, Massachusetts General HospitalCenter for Systems Biology, Massachusetts General HospitalCenter for Systems Biology, Massachusetts General HospitalCenter for Systems Biology, Massachusetts General HospitalPalladium (Pd) is a well-known catalyst in organic chemistry but its use in nanomedicine is limited. Here, the authors design a Pd nanoparticle that triggers the activation of an antitumour prodrugin vivo, which shows efficacy and improves toxicity compared to traditional solvent- and nanoparticle-drug formulations.https://doi.org/10.1038/ncomms15906
spellingShingle Miles A. Miller
Bjorn Askevold
Hannes Mikula
Rainer H. Kohler
David Pirovich
Ralph Weissleder
Nano-palladium is a cellular catalyst for in vivo chemistry
Nature Communications
title Nano-palladium is a cellular catalyst for in vivo chemistry
title_full Nano-palladium is a cellular catalyst for in vivo chemistry
title_fullStr Nano-palladium is a cellular catalyst for in vivo chemistry
title_full_unstemmed Nano-palladium is a cellular catalyst for in vivo chemistry
title_short Nano-palladium is a cellular catalyst for in vivo chemistry
title_sort nano palladium is a cellular catalyst for in vivo chemistry
url https://doi.org/10.1038/ncomms15906
work_keys_str_mv AT milesamiller nanopalladiumisacellularcatalystforinvivochemistry
AT bjornaskevold nanopalladiumisacellularcatalystforinvivochemistry
AT hannesmikula nanopalladiumisacellularcatalystforinvivochemistry
AT rainerhkohler nanopalladiumisacellularcatalystforinvivochemistry
AT davidpirovich nanopalladiumisacellularcatalystforinvivochemistry
AT ralphweissleder nanopalladiumisacellularcatalystforinvivochemistry